OsteoArticular Sepsis in Intensive Care unitS
OSTEOARTICULAR SEPSIS ON EQUIPMENT in Intensive Care and Continuing Care Units in France
Assistance Publique - Hôpitaux de Paris
150 participants
Mar 31, 2025
OBSERVATIONAL
Conditions
Summary
This is an ambispective observational study of patients admitted to intensive care with a diagnosis of joint prosthesis infection (mainly knee and hip prostheses). The main objective of the study is to describe the profile, care trajectories during the stay (before or after surgery) and prognosis of patients admitted to critical care with such an infection. We also aim to compare prognosis between different groups of patients sharing the same profile and care trajectory, and to assess independent risk factors associated with 2-year mortality among the study population. Finally, we will describe the microbiological and resistance profile of severe osteoarticular device infections requiring critical care admission in France. This is a descriptive and analytical observational study open to all French public and private hospitals. Patient data will be retrieved prospectively from patient source files. Only 2-year data (vital status, functional data) will be collected specifically for the study, by telephone contact with the patient or his or her support person.
Eligibility
Inclusion Criteria2
- Patient at least 18 years old.
- Hospitalization in critical care (intensive care unit or continuing care unit) between 2018 and 2022 of at least 48 hours, with prosthetic joint infection (hip, knee or shoulder prosthesis infection) as the main or associated diagnosis.
Exclusion Criteria8
- Infection on osteosynthesis material
- Infection on spinal equipment
- Patient with several infected prostheses
- Recurrence of infection on prosthesis with the same microorganism
- Patient opposing data collection
- Patient under legal protection.
- Pregnant or breast-feeding patient.
- Patient deprived of liberty.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06627842